Abstract
The 3′-ends of both prokaryotic and eukaryotic RNA can be polyadenylated and the effect of polyadenylation is known to increase the stability of transcripts in eukaryotes, whereas it promotes instability in prokaryotes. RNAs are considered as key effectors of virulence mechanisms, since they are directly involved in regulatory pathways in pathogenic bacteria. Deadenylation of RNA is thus an important control point and rate-limiting step of its turnover. RNase AS is a novel identified protein of Mycobacterium tuberculosis, which dramatically hampers mycobacterial virulence in vivo, with a mechanism which is still to be fully defined. Phylogenetic analysis identifies orthologs of RNase AS in all mycobacteria. However, functional data only recently clarified that RNase AS is an exo-ribonuclease, which is highly specific in degrading polyadenylate sequences of RNA. This Review summarizes the current knowledge on structure and function of RNase AS and underscores its role in the process of RNA maturation. An overall description of all mycobacterial ribonucleases hitherto characterized is also provided.
Keywords: Function, ribonucleases, structure, tuberculosis.
Current Medicinal Chemistry
Title:Structure and Function of RNase AS: A Novel Virulence Factor From Mycobacterium tuberculosis
Volume: 22 Issue: 14
Author(s): Maria Romano, Flavia Squeglia and Rita Berisio
Affiliation:
Keywords: Function, ribonucleases, structure, tuberculosis.
Abstract: The 3′-ends of both prokaryotic and eukaryotic RNA can be polyadenylated and the effect of polyadenylation is known to increase the stability of transcripts in eukaryotes, whereas it promotes instability in prokaryotes. RNAs are considered as key effectors of virulence mechanisms, since they are directly involved in regulatory pathways in pathogenic bacteria. Deadenylation of RNA is thus an important control point and rate-limiting step of its turnover. RNase AS is a novel identified protein of Mycobacterium tuberculosis, which dramatically hampers mycobacterial virulence in vivo, with a mechanism which is still to be fully defined. Phylogenetic analysis identifies orthologs of RNase AS in all mycobacteria. However, functional data only recently clarified that RNase AS is an exo-ribonuclease, which is highly specific in degrading polyadenylate sequences of RNA. This Review summarizes the current knowledge on structure and function of RNase AS and underscores its role in the process of RNA maturation. An overall description of all mycobacterial ribonucleases hitherto characterized is also provided.
Export Options
About this article
Cite this article as:
Romano Maria, Squeglia Flavia and Berisio Rita, Structure and Function of RNase AS: A Novel Virulence Factor From Mycobacterium tuberculosis, Current Medicinal Chemistry 2015; 22 (14) . https://dx.doi.org/10.2174/0929867322666150417125301
DOI https://dx.doi.org/10.2174/0929867322666150417125301 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Synthetic Antibiotics for the Treatment of Enterococcus and Campylobacter Infection
Current Topics in Medicinal Chemistry Evolving Larger: Dosing Anti-Tuberculosis (TB) Drugs in an Obese World
Current Pharmaceutical Design Cystic Hygroma with Multiple Benign Bone Lymphangiomas in an Adult Patient: A Rare Entity in the Differential Diagnosis of Multiple Osseous Lesions in Oncology Practice
Current Medical Imaging The Role of Infection in Carotid Plaque Pathogenesis and Stability: The Clinical Evidence
Current Vascular Pharmacology Lead Molecules for Targeted Urease Inhibition: An Updated Review from 2010 -2018
Current Protein & Peptide Science Therapeutic and Protective Potential of Mesenchymal Stem Cells, Pharmaceutical Agents and Current Vaccines Against COVID-19
Current Stem Cell Research & Therapy An Update on Autoinflammatory Diseases
Current Medicinal Chemistry Subject Index To Volume 8
Current Pharmaceutical Design Novel Furan Coupled Quinoline Diamide Hybrid Scaffolds as Potent Antitubercular Agents: Design, Synthesis and Molecular Modelling
Medicinal Chemistry Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases
Current Neuropharmacology New Plates for Different Types of Plate Heat Exchangers
Recent Patents on Mechanical Engineering Emerging Trends in Endometriosis Treatment - Review
Current Women`s Health Reviews Centrality Measures in Biological Networks
Current Bioinformatics Patents Related to Pathogenic Human Coronaviruses
Recent Patents on Biotechnology Identification of Selectivity Determinants in CYP Monooxygenases by Modelling and Systematic Analysis of Sequence and Structure
Current Drug Metabolism Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp)
Current Medicinal Chemistry Polypharmacology in a Single Drug: Multitarget Drugs
Current Medicinal Chemistry Adjunctive Immunotherapy of Mycobacterial Infections
Current Pharmaceutical Design Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones
Mini-Reviews in Medicinal Chemistry Bis(2-aminoimidazolines) and Bisguanidines: Synthetic Approaches, Antiparasitic Activity and DNA Binding Properties
Current Medicinal Chemistry